French biopharmaceutical company Sartorius Stedim Biotech has announced the opening of its new centre for bioprocessing innovation in Marlborough, Massachusetts, US.

The centre encourages teamwork, joint creation, and education directly with clients and outside partners for innovation, utilising Sartorius’ newest technologies in practical bioprocess operations.

In addition to research and service labs, the 5853sqm facility has spaces for customer training and demonstrations. Process development, optimisation, and validation services will also be provided. More than 120 internal and external bioprocessing experts will be able to work at the new hub, which currently houses a team of 50 scientists and product developers.

President of Sartorius North America Maurice Phelan noted that the Greater Boston area offered “an unparalleled ecosystem that fosters innovation, collaboration, and growth.” He admired the area’s “access to world-renowned academic institutions, cutting-edge research facilities and a skilled workforce.”

On the business side, Phelan also mentioned “the region’s robust network of venture capital firms and industry partnerships” which will “provide ample opportunities for strategic collaborations.”

Sartorius Stedim Biotech will add two multi-modality GMP suites in 2025 that will use their equipment and workflows. The suits will enable clients to continue working with Sartorius from the early phases of clinical production of development projects. This will allow the business to broaden its range of solutions while concentrating on creating innovative production techniques for new medicines.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Over the past few years, the firm has expanded its presence in the region. They have a shared lab in Boston’s Seaport District and opened a Customer Interaction Centre for BioProcess Equipment by acquiring WaterSep BioSeparations.

Sartorius Stedim Biotech employs about 1,800 people in North America and more than 100 people across three locations in Malborough.